Loading clinical trials...
Loading clinical trials...
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation
Pharmacokinetics of antibiotics in critically ill neonates, infants and children on extracorporeal membrane oxygenation (ECMO).
The study will investigate whether - with the current dosing regimens of meropenem, piperacillin-tazobactam, amoxicillin-clavulanate, cephazolin, vancomycin, amikacin, teicoplanin and ciprofloxacin - pharmacodynamic targets are attained in a national multicentric clinical setting in pediatric patients on ECMO.
Age
0 - 15 years
Sex
ALL
Healthy Volunteers
No
Queen Fabiola Children's University Hospital
Brussels, Brussels Capital, Belgium
University Hospital
Ghent, Belgium
Universitair hospital
Leuven, Belgium
Start Date
August 19, 2016
Primary Completion Date
July 1, 2026
Completion Date
July 1, 2026
Last Updated
January 16, 2026
300
ESTIMATED participants
Amoxicillin-clavulanate
OTHER
Piperacillin-tazobactam
OTHER
Meropenem
OTHER
Cefazolin
OTHER
Vancomycin
OTHER
Teicoplanin
OTHER
Ciprofloxacin
OTHER
Amikacin
OTHER
Lead Sponsor
University Hospital, Ghent
NCT07052162
NCT04961593
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT02456974